Demonstration only. All companies, products, sources and amounts below are illustrative.
The executive viewClarify the role of two sleep products before expanding the range. Validate the commercial case with customer and cost data.
This is a structured set of review priorities, not an instruction to discontinue a product or a forecast of return.
01Portfolio fit · Partial evidenceReview the sleep range
Two illustrative products share magnesium and an evening-use position. Their complete formulas differ.
The proposition may be difficult to distinguish. Shared ingredients alone do not demonstrate cannibalization.
Next action & supporting sources
Compare customer segments, repeat purchases and channel-level sales before combining or removing a product.
Owner: Product + commercial lead
Source references: S01, S02
02Evidence · Review requiredCheck the new launch brief
The example brief contains a relaxation claim without a supplied product-context evidence assessment.
The claim remains unverified. An ingredient study does not automatically substantiate the finished product.
Next action & supporting sources
Obtain current labels and have a qualified reviewer assess the form, dose, population and proposed wording.
Owner: Regulatory + product lead
Source references: S03
03Commercial assumptions · Scenario onlyBuild a contribution scenario
The illustrative model below uses unit-level contribution, not revenue, to compare options.
Savings depend on demand transfer and genuinely avoidable costs. Neither has been established by a public scan.
Next action & supporting sources
Replace the sample assumptions with finance-approved figures and test downside cases.
Owner: Finance lead
Source references: S04